How do I recognize, confirm, and manage pseudohypernatremia versus true hypernatremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pseudohypernatremia: Recognition, Confirmation, and Management

What is Pseudohypernatremia?

Pseudohypernatremia is a laboratory artifact where measured serum sodium appears falsely elevated due to sample contamination, most commonly with trisodium citrate from catheter-lock solutions used in dialysis catheters. 1 Unlike pseudohyponatremia (which results from increased serum lipids or proteins reducing the aqueous fraction), pseudohypernatremia is almost exclusively an iatrogenic pre-analytical error. 2, 3

Recognition: When to Suspect Pseudohypernatremia

Clinical Red Flags

  • Severe hypernatremia (>170 mmol/L) in an asymptomatic patient – true hypernatremia at this level causes encephalopathy, seizures, or coma 1
  • Discordance between sodium level and clinical presentation – patient appears euvolemic without neurological symptoms despite critically elevated sodium 1
  • Recent blood draw from a dialysis catheter or central line – especially if catheter-lock solutions (Citra-Lock™, trisodium citrate) are used 1
  • Sudden, unexplained spike in sodium from previously normal values without corresponding clinical deterioration 1

High-Risk Scenarios

  • Hemodialysis patients with tunneled catheters using trisodium citrate locks 1
  • Blood samples drawn from the same lumen used for catheter-lock instillation 1
  • Inadequate flushing or aspiration of "dead space" before sample collection 1

Confirmation: Systematic Diagnostic Approach

Step 1: Immediate Repeat Measurement

  • Draw a new sample from a peripheral vein (not from the catheter) within 2 hours 1
  • If sodium normalizes (typically 135-145 mmol/L), pseudohypernatremia is confirmed 1
  • If elevated sodium persists with appropriate clinical symptoms, treat as true hypernatremia 1

Step 2: Verify with Alternative Analyzer

  • Measure sodium on a different analyzer using the same sample 1
  • Concordant results across platforms suggest true hypernatremia, while discordant results point to analytical interference 1
  • Direct ion-selective electrode (ISE) methods are less susceptible to interference than indirect ISE 2, 3

Step 3: Evaluate Sample Collection Technique

  • Review the blood draw procedure systematically: 1
    • Was sample drawn from a catheter with lock solution?
    • Was adequate volume discarded before collection (minimum 5-10 mL)?
    • Was the catheter flushed appropriately before sampling?
  • Check for visible contamination – trisodium citrate may cause sample clotting or unusual appearance 1

Step 4: Calculate Expected Sodium Change

  • True hypernatremia develops gradually – acute rises >10-15 mmol/L in hours without corresponding clinical deterioration are suspicious 1
  • Assess volume status and urine output – true hypernatremia shows signs of dehydration or diabetes insipidus 4

Management Algorithm

If Pseudohypernatremia is Confirmed

  1. Do NOT treat the sodium level – no hypertonic fluid correction is needed 1
  2. Document the error in the medical record to prevent repeated unnecessary interventions 1
  3. Educate nursing and phlebotomy staff on proper catheter sampling technique 1
  4. Implement protocol changes: 1
    • Always discard adequate dead-space volume (≥10 mL) before blood draw
    • Preferentially draw labs from peripheral veins when possible
    • Label samples drawn from catheters to alert laboratory staff
  5. Recheck sodium from peripheral vein to establish true baseline 1

If True Hypernatremia is Confirmed

Treat based on severity and underlying cause: 4

  • Mild hypernatremia (146-150 mmol/L): Increase oral free water intake; address underlying cause 4
  • Moderate hypernatremia (151-160 mmol/L): Oral or IV hypotonic fluids (0.45% saline or D5W); correct at 0.5 mmol/L/hour maximum 4
  • Severe hypernatremia (>160 mmol/L): IV hypotonic fluids with close monitoring; correct no faster than 10-12 mmol/L per 24 hours to avoid cerebral edema 4

Key Differences: Pseudohypernatremia vs. Pseudohyponatremia

Feature Pseudohypernatremia Pseudohyponatremia
Mechanism Sample contamination with sodium-containing solutions [1] Increased serum lipids/proteins reducing aqueous fraction [2,3]
Frequency Rare, iatrogenic [1] More common in hyperlipidemia, hyperproteinemia [2,3,5]
Detection Repeat sample from different site [1] Direct ISE measurement or serum water content [2,3]
Clinical significance None – purely artifactual [1] May reflect underlying metabolic disorder [5]
Modern analyzers Not prevented by current technology [1] Largely eliminated by direct ISE methods [3]

Common Pitfalls to Avoid

  • Treating severe "hypernatremia" without confirming the diagnosis – can lead to unnecessary and potentially harmful interventions 1
  • Assuming all analyzer results are accurate – severe discordance with clinical picture mandates repeat testing 1
  • Drawing labs from catheters without adequate dead-space discard – the most common cause of pseudohypernatremia 1
  • Failing to communicate with laboratory staff about sample source and collection technique 1
  • Not documenting pseudohypernatremia in the record – risks repeated misinterpretation and inappropriate treatment 1

Prevention Strategies

Implement standardized catheter sampling protocols: 1

  • Discard minimum 10 mL before blood draw from any catheter
  • Use peripheral venipuncture for critical lab values when feasible
  • Label all catheter-drawn samples clearly
  • Educate staff on catheter-lock solutions and contamination risk

Maintain high clinical suspicion when sodium values are discordant with patient presentation, especially in dialysis patients with central catheters 1

Related Questions

What is the treatment for pseudo hyponatremia?
What is pseudohyponatremia?
How is pseudo hyponatremia (false low sodium levels) managed?
What is the management approach for a patient with suspected pseudohyponatremia, particularly those with elevated lipid or protein levels, such as in multiple myeloma or hypertriglyceridemia?
Why is the low sodium observed in hyperglycemia a true dilutional hyponatremia rather than pseudohyponatremia?
Why did the physician miss the diagnosis of Hashimoto’s thyroiditis in a patient presenting with classic signs and symptoms of hypothyroidism?
Should I call emergency services for someone with sudden breathlessness at rest, lower‑back pain, generalized body aches, nausea, and dizziness?
In an adult with primary Sjögren’s syndrome and moderate‑to‑severe systemic disease (high ESSDAI, active interstitial lung disease, severe fatigue or pain) who has failed hydroxychloroquine, pilocarpine, and topical secretagogues, can tofacitinib be used off‑label, and what dose, monitoring, and alternative therapies are recommended?
How should I take a comprehensive history for a patient presenting with abdominal distension, vaginal bleeding and possible molar pregnancy?
Can an obese patient with Sjögren’s syndrome be treated with azathioprine as first‑line immunosuppression and tirzepatide for obesity, and what are the appropriate dosing, monitoring, and safety considerations?
What is pseudohyponatremia, how can it be distinguished from true hyponatremia, and what is the appropriate management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.